OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, et al.
Journal of Molecular Histology (2020) Vol. 51, Iss. 6, pp. 613-628
Open Access | Times Cited: 426

Showing 1-25 of 426 citing articles:

Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis
Preeti Malik, Karan Patel, Cândida Pinto, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 253-262
Open Access | Times Cited: 534

Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 218

COVID-19-associated opportunistic infections: a snapshot on the current reports
Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
Clinical and Experimental Medicine (2021) Vol. 22, Iss. 3, pp. 327-346
Open Access | Times Cited: 132

Vitamin D supplementation for the treatment of COVID-19: a living systematic review
Julia Kristin Stroehlein, Julia Wallqvist, Claire Iannizzi, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 108

Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank
Eric Yuk Fai Wan, Sukriti Mathur, Ran Zhang, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 8, pp. 1718-1727
Closed Access | Times Cited: 87

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 71

Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management
Zarina Mohd Zawawi, Jeevanathan Kalyanasundram, Rozainanee Mohd Zain, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6142-6142
Open Access | Times Cited: 45

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43

Covid-19 Infection in India: A Comparative Analysis of the Second Wave with the First Wave
Arnab Sarkar, Alok K. Chakrabarti, Shanta Dutta
Pathogens (2021) Vol. 10, Iss. 9, pp. 1222-1222
Open Access | Times Cited: 89

Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design
Hao Lv, Lei Shi, Joshua William Berkenpas, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 84

Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19
Matthew Kheir, Farah Saleem, Christy Wang, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248358-e0248358
Open Access | Times Cited: 74

Cancer as a prospective sequela of long COVID‐19
Geetanjali Saini, Ritu Aneja
BioEssays (2021) Vol. 43, Iss. 6
Open Access | Times Cited: 74

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Jon Hazeldine, Janet M. Lord
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73

SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Abbas Khan, Taimoor Ashraf Khan, Shughla Ali, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112176-112176
Open Access | Times Cited: 71

Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
Louisa Ruhl, Isabell Pink, Jenny F. Kühne, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70

Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
Mar Pacheco‐Herrero, Luis O. Soto-Rojas, Charles R. Harrington, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 60

Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 51

Iron and iron-related proteins in COVID-19
Erin Suriawinata, Kosha J. Mehta
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 969-991
Open Access | Times Cited: 47

COVID-19 detection on chest X-ray images using Homomorphic Transformation and VGG inspired deep convolutional neural network
Gerosh Shibu George, Pratyush Raj Mishra, Panav Sinha, et al.
Journal of Applied Biomedicine (2022) Vol. 43, Iss. 1, pp. 1-16
Open Access | Times Cited: 42

Experimental Models of COVID-19
Luis A. Caldera-Crespo, Michael J. Paidas, Sabita Roy, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 41

Tissue factor in COVID-19-associated coagulopathy
Saravanan Subramaniam, Hema Kothari, Markus Bosmann
Thrombosis Research (2022) Vol. 220, pp. 35-47
Open Access | Times Cited: 38

SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19
Ariana Arduini, Frederique Laprise, Chen Liang
Viruses (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top